Immunome
IMNM
IMNM
199 hedge funds and large institutions have $2.54B invested in Immunome in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 47 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
25.92% less ownership
Funds ownership: 129.03% → 103.11% (-26%)
77% less call options, than puts
Call options by funds: $7.08M | Put options by funds: $30.5M
Holders
199
Holding in Top 10
4
Calls
$7.08M
Puts
$30.5M
Top Buyers
| 1 | +$84.5M | |
| 2 | +$65.5M | |
| 3 | +$34.1M | |
| 4 |
Morgan Stanley
New York
|
+$25.2M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
+$20.4M |
Top Sellers
| 1 | -$151M | |
| 2 | -$61.3M | |
| 3 | -$37M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$26.2M |
| 5 |
ES
Enavate Sciences
Menlo Park,
California
|
-$25.7M |
